Its influence on fibroblast activity and collagen synthesis supports studies investigating joint recovery, injury repair, and musculoskeletal regeneration under non-anabolic conditions

Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, market and other conditions, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process, potential adverse effects arising from the testing or use of products utilizing the DehydraTECH technology, the Companys ability to maintain existing collaborations and realize the benefits thereof, delays or cancellations of planned R&D that could occur related to pandemics or for other reasons, and other factors which may be identified from time to time in the Companys public announcements and periodic filings with the US Securities and Exchange Commission on EDGAR

However, starting in July 2026, a new program called the BALANCE Model may give eligible Medicare Part D beneficiaries access to certain GLP-1 weight loss medications for a $50 copay
Autophagy: cellular and molecular mechanisms
10.3389/fimmu.2017.01239 27 DouX.LiS.HuL.DingL.MaY.MaW.et al (2018)
Reaching this level of protein intake can be challenging when taking a GLP-1 medication, as these medications reduce appetite